Healthcare AI Acq -CW23HAIWFPreferred / convertible

13F holders, Q4 2024 (December 31)
3holders −32
0new positions
31sold out
$3.27avg. 13F price*

At the end of Q4 2024, 3 institutions reported holding Healthcare AI Acq -CW23 (HAIWF) in their 13F filings, down 32 from Q3 2024. 0 opened new positions and 31 sold out. The largest holders were Barclays PLC ($718K), Rivernorth Capital Management, LLC ($642) and Context Capital Management, LLC ($119).

Company
Healthcare AI Acq -CW23
CUSIP
G4373K117
Latest filing quarter
Q2 2026

History

Number of 13F holders

010203040 Q1 2024: 36Q1 2024Q2 2024: 33Q2 2024Q3 2024: 35Q3 2024Q4 2024: 3Q4 2024Q3 2025: 1Q3 2025Q4 2025: 1Q4 2025Q1 2026: 1Q1 2026Q2 2026: 1Q2 2026

Total Exit/New Position Q3 2024 → Q4 2024

InstitutionsTotal Value
New Positions0$0
Exits31$142K

All 13F filers, Q3 2024 → Q4 2024: 5,420,952 shares sold, net −5,420,952 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 3 holders

Barclays PLC — No change 62,809 $718K
Rivernorth Capital Management, LLC — No change 57,299 $642
Context Capital Management, LLC — No change 99,949 $119

"% of holder's portfolio" is HAIWF's weight in each manager's 13F, not the share of Healthcare AI Acq -CW23 the manager owns.